NASDAQ

Vaccitech, the company that developed the AstraZeneca COVID-19 shot, files for a Nasdaq IPO

Posted On: May 11, 2021   |   Posted By: Fierce Biotech

Vaccitech, the company that developed the AstraZeneca COVID-19 shot, files for a Nasdaq IPO badams
Mon, 04/12/2021 - 07:32

Continue reading ...

 






The last Posts from "Fierce Biotech"